Clinical impact of sexual dimorphism in non‐alcoholic fatty liver disease (NAFLD) and non‐alcoholic steatohepatitis (NASH)

P Burra, D Bizzaro, A Gonta, S Shalaby… - Liver …, 2021 - Wiley Online Library
NAFLD/NASH is a sex‐dimorphic disease, with a general higher prevalence in men. Women
are at reduced risk of NAFLD compared to men in fertile age, whereas after menopause …

Transformable soft liquid metal micro/nanomaterials

M Zhang, S Yao, W Rao, J Liu - Materials Science and Engineering: R …, 2019 - Elsevier
Liquid metal is a liquid-state metallic material with a low melting point at or around room
temperature. Owing to their high thermal or electrical conductivity, low viscosity and superior …

A machine learning model to predict hepatocellular carcinoma response to transcatheter arterial chemoembolization

A Morshid, KM Elsayes, AM Khalaf… - Radiology: Artificial …, 2019 - pubs.rsna.org
Purpose To evaluate a fully automated machine learning algorithm that uses pretherapeutic
quantitative CT image features and clinical factors to predict hepatocellular carcinoma …

DEB-TACE: a standard review

F Melchiorre, F Patella, L Pescatori, F Pesapane… - Future …, 2018 - Taylor & Francis
Drug-eluting bead transarterial chemoembolization (DEB-TACE) is a relative new
endovascular treatment based on the use of microspheres to release chemotherapeutic …

PU. 1/microRNA-142-3p targets ATG5/ATG16L1 to inactivate autophagy and sensitize hepatocellular carcinoma cells to sorafenib

K Zhang, J Chen, H Zhou, Y Chen, Y Zhi, B Zhang… - Cell Death & …, 2018 - nature.com
Sorafenib is currently the only systemic agent approved for treatment of advanced
hepatocellular carcinoma (HCC). However, intrinsic and acquired resistance to sorafenib …

Regulation of tumor microenvironment for pancreatic cancer therapy

X Huang, L Ding, X Liu, R Tong, J Ding, Z Qian, L Cai… - Biomaterials, 2021 - Elsevier
Pancreatic cancer (PC) is one kind of the most lethal malignancies worldwide, owing to its
insidious symptoms, early metastases, and negative responses to current therapies. With an …

Hypoxia and tumor angiogenesis in the era of hepatocellular carcinoma transarterial loco-regional treatments

M Petrillo, F Patella, F Pesapane, MB Suter… - Future …, 2018 - Taylor & Francis
This review focuses upon interactions and potential therapeutic targets in the 'vicious
cycle'between hypoxia and neoangiogenesis following treatment of hepatocellular …

Recent advances and applications of microspheres and nanoparticles in transarterial chemoembolization for hepatocellular carcinoma

G Jia, J Van Valkenburgh, AZ Chen… - Wiley …, 2022 - Wiley Online Library
Transarterial chemoembolization (TACE) is a recommended treatment for patients suffering
from intermediate and advanced hepatocellular carcinoma (HCC). As compared to the …

Intraarterial therapies for the management of hepatocellular carcinoma

T Garg, A Shrigiriwar, P Habibollahi, M Cristescu… - Cancers, 2022 - mdpi.com
Simple Summary Hepatocellular carcinoma is the most common liver cancer, leading to
approximately 700,000 deaths worldwide and 30,000 deaths in the United States every …

Development and characterization of gel-in-water nanoemulsion as a novel drug delivery system

J Fardous, Y Omoso, A Joshi, K Yoshida… - Materials Science and …, 2021 - Elsevier
The effective delivery of anti-cancer drugs with minimal side effects and better therapeutic
efficacy has remained an active area of research for many decades. Organogels have …